Functional redundancy of Ets1 and Ets2

Blood

Volumn 114, Issue 5, 2009, Pages 934-935

  Oettgen, Peter ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ONCOPROTEIN; PROTEIN ETS1; PROTEIN ETS2; TRANSCRIPTION FACTOR ELF 1; UNCLASSIFIED DRUG;

ANGIOGENESIS; APOPTOSIS; CARCINOGENESIS; EMBRYO DEVELOPMENT; ENDOTHELIUM CELL; HOMOZYGOSITY; NONHUMAN; NOTE; PRIORITY JOURNAL; T LYMPHOCYTE; TROPHOBLAST;

EID: 70449480554     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2009-05-221812     Document Type: Note

References (7)

1. Wei G, Srinivasan R, Cantemir-Stone CZ, et al. Ets1 and Ets2 are required for endothelial cell survival during embryonic angiogenesis. Blood. 2009;114:1123-1130.
2. Dittmer J. The biology of the Ets1 proto-oncogene. Mol Cancer. 2003;2:29.
3. Barton K, Muthusamy N, Fischer C, et al. The Ets-1 transcription factor is required for the development of natural killer cells in mice. Immunity. 1998;9:555-563. (Pubitemid 28499206)
4. Yamamoto H, Flannery ML, Kupriyanov S, et al. Defective trophoblast function in mice with a targeted mutation of Ets2. Genes Dev. 1998;12:1315-1326. (Pubitemid 28213407)
5. Man AK, Young LJ, Tynan JA, et al. Ets2-dependent stromal regulation of mouse mammary tumors. Mol Cell Biol. 2003;23:8614-8625. (Pubitemid 37433366)
6. Pourtier-Manzanedo A, Vercamer C, Van Belle E, et al. Expression of an Ets-1 dominant-negative mutant perturbs normal and tumor angiogenesis in a mouse ear model. Oncogene. 2003;22:1795-1806. (Pubitemid 36513139)
7. Huang X, Brown C, Ni W, et al. Critical role for the Ets transcription factor ELF-1 in the development of tumor angiogenesis. Blood. 2006;107:3153-3160.